Trials / Completed
CompletedNCT00871585
Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide
Non-interventional Observational Study to Evaluate Change of PSA Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide in Combination With Medical or Surgical Castration
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 340 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- Male
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, non-comparative, non-interventional, observational study to collect and analyse real life environment data on advanced prostate cancer patients receiving combination treatment of medical or surgical castration and bicalutamide according to routine medical practice in Croatia. The main aim is to evaluate change of PSA level and prescribing practices based on prostate cancer stage.
Conditions
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2009-03-30
- Last updated
- 2010-04-15
Locations
15 sites across 1 country: Croatia
Source: ClinicalTrials.gov record NCT00871585. Inclusion in this directory is not an endorsement.